Press Release
FERRING PHARMACEUTICALS LAUNCHES NEW WEB SITE OFFERING INFORMATION ON INFERTILITY TREATMENT
Web site launched at 57th Annual American Society for Reproductive Medicine (ASRM) Meeting in Orlando
Contact: Andrea Thornton Kovak-Likly Communications (203) 762-8833
ORLANDO, FL - October 24, 2001 - Ferring Pharmaceuticals announced today the launch of a new Web site that provides both consumers and professionals with comprehensive information on infertility and its treatment. The new site, www.ferringfertility.com, launched at the 57th annual American Society for Reproductive Medicine (ASRM) meeting in Orlando, FL, provides exclusive access to educational information developed by the ASRM. The site includes, and will be regularly updated with, educational materials on infertility, commonly used treatments and tips on understanding health insurance coverage and managing costs.
An additional resource on the Web site is an online patient support network called FerringCare. Individuals who currently use Ferring products can access the network to obtain patient support such as package inserts and step-by-step instructions for drug administration. FerringCare was also designed to offer infertility professionals exclusive Web sites customized to meet their patients’ specific needs.
“For the more than six million individuals in the U.S. affected by infertility, the medical process can be both stressful and overwhelming,” said Wayne Anderson, President, Ferring Pharmaceuticals. “Our goal is to meet our patients’ needs by providing them with educational resources, ongoing support and highly effective, high purity products.”
Additional highlights of the Web site include:
* Infertility information: offers tips such as Managing Costs, Understanding Health Insurance Coverage and Investigating Your Infertility Coverage; supplies detailed information on Ferring’s products.
* Resources: provides online access to educational materials developed by the ASRM such as a glossary of terms and Understanding Infertility; provides professionals with practice-customized patient information tools and information on upcoming events such as seminars, symposiums and referral events.
* Ferring Pharmaceuticals Inc., headquartered in Tarrytown, NY, is part of the Ferring Group, a privately owned, international biopharmaceutical company that specializes in the research, development and commercialization of compounds in general and pediatric endocrinology, urology, gastroenterology, obstetrics/gynecology and infertility. For more information, call 1-888-337-7464 or visit the Ferring Web site at www.ferringusa.com.
# # #